7 unchanged sentences
Name Age Position
−Removed: Albert Bourla 62 Chairman of the Board since January 2020 and Chief Executive Officer since January 2019.
+Added: Albert Bourla, DVM, Ph.D.
+Added: 63 Chairman of the Board since January 2020 and Chief Executive Officer since January 2019.
Chief Operating Officer from January 2018 until December 2018.
3 unchanged sentences
Our Director since February 2018.
−Removed: Chris Boshoff 60 Chief Oncology Officer, Executive Vice President since December 2023.
+Added: Andrew Baum, MA, BM ChB
+Added: 55 Chief Strategy and Innovation Officer and Executive Vice President since 2024.
+Added: Prior to joining Pfizer, he was Head of Global Healthcare - Managing Director Equity Research at Citigroup from 2011 until 2024.
+Added: Chris Boshoff, MD, FRCP, FMedSci, Ph.D.
+Added: 61 Chief Scientific Officer and President, Research & Development, since January 2025.
+Added: Chief Oncology Officer, Executive Vice President from December 2023 until December 2024.
Chief Oncology Research and Development Officer and Executive Vice President from July 2023 until December 2023.
3 unchanged sentences
Executive Vice President and Chief Financial Officer, CVS Health Corporation (a diversified health solutions company), from January 2010 until November 2018.
−Removed: Director of Tapestry, Inc.
−Removed: from 2014 to 2023.
−Removed: Director of Haleon plc.
+Added: Served as Director of Haleon plc from March 2023 to December 2024.
Alexandre de Germay 57 Chief International Commercial Officer, Executive Vice President since December 2023.
4 unchanged sentences
from 2013 until 2016.
−Removed: Mikael Dolsten 65 Chief Scientific Officer, President, Pfizer Research and Development since July 2023.
−Removed: Chief Scientific Officer and President, Worldwide Research, Development and Medical from January 2019 until July 2023.
−Removed: President of Worldwide Research and Development from December 2010 until December 2018.
−Removed: Senior Vice President;
−Removed: President of Worldwide Research and Development from May 2010 until December 2010.
−Removed: Senior Vice President;
−Removed: President of Pfizer BioTherapeutics Research & Development Group from October 2009 until May 2010.
−Removed: Director of Agilent Technologies, Inc, and Vimian Group AB.
Lidia Fonseca 56 Chief Digital and Technology Officer, Executive Vice President since January 2019.
1 unchanged sentence
Senior Vice President of Laboratory Corporation of America Holdings from 2008 until March 2013.
−Removed: Director of Tegna, Inc.
−Removed: from 2014 to 2023.
Director of Medtronic plc.
−Removed: Johnson 62 Chief Compliance, Quality and Risk Officer, Executive Vice President since January 2019.
−Removed: Executive Vice President, Chief Compliance and Risk Officer from December 2013 until December 2018.
−Removed: Senior Vice President and Associate General Counsel from October 2006 until December 2013.
−Removed: Lankler 58 General Counsel, Executive Vice President since December 2013.
+Added: Lankler 59 Chief Legal Officer, Executive Vice President since January 2025.
+Added: General Counsel, Executive Vice President from December 2013 until December 2024.
Corporate Secretary from January 2014 until February 2014.
5 unchanged sentences
previously co-led McKinsey & Company’s Global Pharmaceuticals & Medical Products practice from 2015 to 2018.
−Removed: Michael McDermott 58 Chief Global Supply Officer, Executive Vice President since January 2022.
+Added: Michael McDermott 59 Chief Global Supply and Quality Officer, Executive Vice President since January 2025.
+Added: Chief Global Supply Officer, Executive Vice President from 2022 until December 2024.
President of Pfizer Global Supply from 2018 until 2021.
9 unchanged sentences
Senior Vice President, Policy, External Affairs and Communications from December 2009 until December 2010.
+Added: Director of UL Solutions Inc.
2024 Form 10-K
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.